Total amount raised
$57.8 Million
Latest funding date
09/01/2023
Location
NeuroFlow has successfully raised funding over 11 rounds, with the latest being a grant. The company is backed by 19 investors, including Concord Health Partners and SEMCAP.
Keep reading to explore the intricacies of NeuroFlow's fundraising journey and the investors backing this innovative platform.
What Is NeuroFlow?
NeuroFlow is a HIPAA-compliant digital health platform that optimizes the delivery, tracking, and assessment of behavioral healthcare. Based in Philadelphia, Pennsylvania, the company operates in various sectors including fitness, health care, mental health, mHealth, and wellness.
With an employee count ranging from 101 to 250, NeuroFlow has made significant strides in the digital health industry. The company has raised funds through 11 funding rounds and has acquired four organizations to bolster its capabilities.
How Much Funding Has NeuroFlow Raised?
- Round Name: Seed
- Amount Raised: USD 2,280,000
- Date: September 2018
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop and expand the platform's capabilities and user base.
- Round Name: Series A
- Amount Raised: USD 7,500,000
- Date: December 2019
- Lead Investors: Builders VC
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To optimize product offerings and expand the user base.
- Round Name: Series B
- Amount Raised: USD 20,000,000
- Date: January 2021
- Lead Investors: Magellan Health Services
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale operations and support growth in data analytics, AI, and direct health record integrations.
- Round Name: Series C
- Amount Raised: USD 25,000,000
- Date: October 2022
- Lead Investors: SEMCAP
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further expand the platform's capabilities and market reach.
- Round Name: Series Unknown
- Amount Raised: Not publicly disclosed
- Date: September 2023
- Lead Investors: Concord Health Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To continue scaling and enhancing the platform's offerings.
- Round Name: Grant
- Amount Raised: EUR 2,500,000
- Date: May 2025
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support ongoing research and development initiatives.
Total Amount Raised: USD 55,529,374
Current Valuation: Not publicly disclosed
Key Investors
- Concord Health Partners
- Details: Concord Health Partners is a healthcare-focused investment firm that partners with innovative companies to improve healthcare quality and efficiency. They have a strategic approach to investing in companies that can drive meaningful change in the healthcare sector.
- Investment Focus Areas: Healthcare, technology, innovation
- Notable Investments: Not publicly disclosed
- SEMCAP
- Details: SEMCAP is an investment firm that focuses on growth-stage companies in the healthcare, education, and technology sectors. They aim to support companies that have the potential to make a significant impact in their respective fields.
- Investment Focus Areas: Healthcare, education, technology
- Notable Investments: Not publicly disclosed
- Magellan Health
- Details: Magellan Health is a healthcare company that provides services in behavioral health, specialty health, and pharmacy management. They focus on managing complex healthcare needs and improving patient outcomes.
- Investment Focus Areas: Behavioral health, specialty health, pharmacy management
- Notable Investments: Not publicly disclosed
- National Science Foundation
- Details: The National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering. They aim to promote the progress of science and advance national health, prosperity, and welfare.
- Investment Focus Areas: Science, engineering, education
- Notable Investments: Not publicly disclosed
- Builders VC
- Details: Builders VC is a venture capital firm that invests in early-stage companies with the potential to disrupt traditional industries. They focus on partnering with entrepreneurs who are building innovative solutions to solve real-world problems.
- Investment Focus Areas: Technology, healthcare, industrials
- Notable Investments: Not publicly disclosed
What's Next for NeuroFlow?
NeuroFlow stands at the cusp of significant growth opportunities, driven by the increasing demand for telehealth solutions and the integration of behavioral health with overall healthcare. The company plans to expand its operations, enhance data analytics, and integrate AI capabilities, addressing the unmet need for comprehensive mental health care. With a user base that has grown tenfold to over 330,000, the potential for further expansion is substantial.
Future fundraising opportunities appear promising, as the company continues to scale its platform and technology. The successful Series B round, backed by Magellan Health, indicates strong investor confidence, suggesting that additional funding rounds could be on the horizon to support further growth and technological advancements.
However, challenges remain. Ensuring effective integration of behavioral health with primary care, managing rapid growth, and maintaining service quality are critical hurdles. Additionally, the overburdened healthcare system may pose difficulties in consistent and adequate treatment delivery. Despite these challenges, NeuroFlow's strategic partnerships and innovative solutions position it well for future success.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like NeuroFlow and gather other critical business insights.
Sign up for free to start unlocking valuable information that can drive your sales success.
